Nivolumab (anti-PD-1)
Nivolumab (anti-PD-1) is a genetically engineered, fully human immunoglobulin (Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1 (PD-1,PCD-1) with immune checkpoint inhibitory and antineoplastic activities. MW : 143.597 KD.
| Trivial name | BMS-936558, ONO-4538, MDX-1106 |
| Catalog Number | A2002 |
| CAS# | 946414-94-4 |
| Size | 1mg |
| Supplier Page | http://www.selleckchem.com/products/nivolumab.html |
| Additional Information | https://file.selleck.cn/downloads/struct/nivolumab-chemical-structure-a2002.gif |